United States · FDA National Drug Code directory
Lidocaine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51004-2105_d1233ce4-5401-402f-b434-7999af2edc40
- Product NDC
- 51004-2105
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Lidocaine Hydrochloride and Epinephrine Bitartrate
- Labeler
- Novocol Pharmaceutical of Canada, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190318
- Source listing expiry
- 20271231
Source-listed ingredients
- LIDOCAINE HYDROCHLORIDE — 20 mg/mL
- EPINEPHRINE BITARTRATE — .01 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 50 CARTRIDGE in 1 CARTON (51004-2105-0) / 1.7 mL in 1 CARTRIDGE · 51004-2105-0
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →